億田智能(300911.SZ):分別與SMEG、思美科簽署經銷協議
格隆匯7月29日丨億田智能(300911.SZ)公佈,公司於近日與SMEG S.p.A.斯麥格股份公司(以下簡稱“SMEG”)在嵊州簽署了《經銷協議》(以下簡稱“《合同一》”),合同有效期爲3年;公司與思美科(深圳)家用電器有限公司(以下簡稱“思美科”)於近日在嵊州簽署了《經銷協議》(以下簡稱“《合同二》”),合同有效期爲3年。公司同意在《合同一》《合同二》項下的“區域”內進行產品的進口與分銷業務;SMEG、思美科擬根據《合同一》《合同二》條款指定經銷商負責產品的銷售與推廣,經銷商亦同意向SMEG採購產品並在約定區域內進行分銷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.